Erasca, Inc.

ERAS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
4 Jun 21, 2024 FORM 4 SUBMISSION
144 Jun 17, 2024
SC 13G May 31, 2024 SC 13G
SC 13G May 29, 2024 SC 13G
SC 13G May 28, 2024
4 May 22, 2024 FORM 4 SUBMISSION
424B5 May 17, 2024 424B5
8-K May 17, 2024 8-K
EFFECT May 16, 2024
8-K May 16, 2024 8-K
144 May 15, 2024
CORRESP May 14, 2024
UPLOAD May 14, 2024
S-3 May 9, 2024 S-3
S-8 May 9, 2024 S-8
10-Q May 8, 2024 10-Q
8-K May 8, 2024 8-K
ARS Apr 26, 2024 ARS
DEFA14A Apr 26, 2024 DEFA14A
DEF 14A Apr 26, 2024 DEF 14A
144 Apr 15, 2024
8-K Mar 28, 2024 8-K
10-K Mar 27, 2024 10-K
← Newer Page 7 of 14 · 350 filings Older →